Industry Applauds Marti Nomination As US IP Enforcement Coordinator
The US IP industry is applauding the nomination of trademark attorney Daniel Marti to be the next US Intellectual Property Enforcement Coordinator.
Original news and analysis on international IP policy
The US IP industry is applauding the nomination of trademark attorney Daniel Marti to be the next US Intellectual Property Enforcement Coordinator.
Biosimilar medicines might prove to be a new reservoir for innovation for the pharmaceutical industry. However, the complexity of their manufacture needs a stringent regulatory framework, according to the industry.
The United Nations Joint Inspection Unit (JIU) has issued a substantive analysis of management and administration in the UN World Intellectual Property Organization. And while the report highlights significant progress in a number of areas, it offers a list of ways WIPO can do better – including on transparency and sorting out staff concerns and strengthening member state oversight.
The World Health Organization this week is holding its first conference on health and climate change. The major objective of the conference is to raise awareness on the impact of climate change on health, according to the WHO, which said it aims to strengthen its voice in the debate.
The inclusion of intellectual property in the ongoing negotiations of the Regional Comprehensive Economic Partnership between 16 countries, most of them Asian, is raising concerns about "TRIPS-plus" measures that could jeopardise generic drugs production in India, according to Médecins Sans Frontières.
Faced with the worst outbreak of Ebola since its discovery some 40 years ago, the world is scrambling for treatments. A World Health Organization-convened panel of experts has decided it is ethical to use experimental treatments. Why is there no treatment available even after 40 years? Market failure, not intellectual property rights, says the WHO.
A group of countries has submitted a new proposal to the upcoming meeting of the World Intellectual Property Organization budget committee to allow the continued participation of indigenous peoples representatives in WIPO’s committee on traditional knowledge and genetic resources.
Drug regulatory authorities are meeting this week in Rio de Janeiro, Brazil to discuss global regulatory issues such as vaccine regulation, falsified products, and pharmacovigilance. A “pre-conference” focused on biosimilars, with civil society warning on barriers to access to those products.
The Washington Post story, How patent reform’s fraught politics have left USPTO still without a boss (July 30), is a vivid account of how patent reform has divided the US economy, preempting a possible replacement for David Kappos who stepped down 18 months ago. The division is even bigger than portrayed. Universities have lined up en masse to oppose reform, while main street businesses that merely use technology argue for reform. Reminiscent of the partisan divide that has paralyzed US politics, this struggle crosses party lines and extends well beyond the usual inter-industry debates. Framed in terms of combating patent trolls through technical legal fixes, there lurks a broader economic concern – to what extent ordinary retailers, bank, restaurants, local banks, motels, realtors, and travel agents should bear the burden of defending against patents as a cost of doing business, writes Brian Kahin.
The European Commission recently launched a public consultation on the protection of geographical indications for non-agricultural products.
Intellectual Property Watch is pleased to announce a joint internship opportunity with the DiploFoundation/Geneva Internet Platform in Geneva, covering events and issues related to internet governance.
The recent case of a monkey selfie that went viral on the web raised thorny issues of ownership between a (human) photographer and Wikimedia. Two attorneys from Morrison & Foerster sort out the relevant copyright law.